000 01603 a2200493 4500
005 20250517080729.0
264 0 _c20160928
008 201609s 0 0 eng d
022 _a1471-2407
024 7 _a10.1186/s12885-016-2131-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJungk, Christine
245 0 0 _aChemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients.
_h[electronic resource]
260 _bBMC cancer
_cFeb 2016
300 _a81 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aCarmustine
_xadministration & dosage
650 0 4 _aCombined Modality Therapy
_xadverse effects
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aGlioma
_xcomplications
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Grading
650 0 4 _aNeoplasm Recurrence, Local
_xdrug therapy
650 0 4 _aPulmonary Fibrosis
_xchemically induced
650 0 4 _aSurvival Analysis
650 0 4 _aTreatment Outcome
700 1 _aChatziaslanidou, Despina
700 1 _aAhmadi, Rezvan
700 1 _aCapper, David
700 1 _aBermejo, Justo Lorenzo
700 1 _aExner, Janina
700 1 _avon Deimling, Andreas
700 1 _aHerold-Mende, Christel
700 1 _aUnterberg, Andreas
773 0 _tBMC cancer
_gvol. 16
_gp. 81
856 4 0 _uhttps://doi.org/10.1186/s12885-016-2131-6
_zAvailable from publisher's website
999 _c25721847
_d25721847